Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,368 public trials 407 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Completed

Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery

NCT01835145

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +17 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 228 locations
View Trial Details
Completed

Phase 1B Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Participants With Advanced Melanoma

NCT03084640

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of Colorado Aurora, Colorado, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • University of Pittsburgh Medical Center - Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

A Phase 2 Study to Assess the Safety and Efficacy of IMO-2125 With 8 mg Ipilimumab in Patients With Metastatic Melanoma

NCT02644967

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Moffitt Cancer Center Research Institute Tampa, Florida, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
View Trial Details
Completed

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

NCT02404441

Conditions
Anaplastic Thyroid Cancer, Breast Diseases, Breast Neoplasms, +27 more
Locations
  • The Sidney Kimmel Cancer Center at Johns Hopkins Hospital Johns Hopkins Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Oregon Health and Science University SC-10 Portland, Oregon, United States
  • Sarah Cannon Research Institute SCRI RC Nashville, Tennessee, United States
View all 41 locations
View Trial Details

Related conditions